Bio and clinical plants feature in 2011 FOYA honours
January 25, 2011Manufacturing and Production MedImmune, Merck & Co, Novartis, Pfizer, Roche, Shire HGT, pharma manufacturing
Three US and three European manufacturing plants have been shortlisted for the annual Facility of the Year awards, with the …
GSK skin cancer drugs moves into phase III
January 25, 2011Research and Development BRAF V600 mutation, Cancer, Duchenne Muscular Dystrophy, GSK, GSK1120212, GSK2118436, GSK968, GlaxoSmithKline, melanoma, skin cancer
GlaxoSmithKline has begun late-stage trials of two new drugs for advanced or metastatic melanoma patients. GSK2118436 and GSK1120212 are being …
SHL GM Frank Isaksson to speak at the 2011 Injectable Drug Delivery Conference
January 25, 2011Manufacturing and Production, Medical Communications auto injector, autoinjector, frank isaksson, injectable drug delivery
With a steadily increasing number of biologics coming to market, the demand for auto injectors and similar devices continues to …
Axon makes US appointment
January 24, 2011Medical Communications AXON Communications, Mark Khan, appointment, medical communications
Richmond, UK-based comms agency Axon Communications has expanded its stateside operations, appointing Mark Khan as VP of client services and …
Digital Pharma: Pfizer UK’s online surgery (case study)
January 24, 2011Medical Communications Digital Pharma blog, Facebook advertising, Google Adwords, ManMOT, PR, Pfizer, Twitter, blogs, male health
Pfizer UK’s online male health clinic Man MOT was launched last summer to offer men confidential advice and information about …
Novartis MS drug steals march over Merck rival
January 24, 2011Sales and Marketing Cladribine, MS, Merck KGaA, Novartis, fingolimod, gilenya, multiple sclerosis
Novartis’ oral multiple sclerosis Gilenya could be on the European market in just three months after winning the backing of …
Novartis offers $470m to boost personalised cancer treatment
January 24, 2011Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine
Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …
Contract research news in brief
January 24, 2011Research and Development AMRI, Applied Clinical Intelligence, Cenix Bioscience, Clinipace Worldwide, ICON, PPD, Pacific Biomarkers, monoclonal antibody
PPD sets up a monoclonal antibody JV in Singapore, plus updates from Icon plc, Cenix Bioscience, Clinipace Worldwide, Pacific Biomarkers, …
OgilvyHealthPR appoints Wendy Gerber and Tania Kouprach-Rolandi
January 24, 2011Medical Communications OgilvyHealthPR, Tania Kouprach-Rolandi, Wendy Gerber, appointment, medical communications
OgilvyHealthPR has strengthened its London team with the appointments of Wendy Gerber and Tania Kouprach-Rolandi, who will focus on HIV, …
Ian Dickety and Sidrah Qureshi join ScopeMedical
January 21, 2011Medical Communications Ian Dickety, ScopeMedical, Sidrah Qureshi, appointments, medical communications
Kent-based med comms agency ScopeMedical has made two new appointments to its team.Starting at the agency are junior digital developer …
Boehringer’s Pradaxa advertising breaches Code
January 21, 2011Medical Communications ABPI, Bayer Schering Pharma, Boehringer Ingelheim, Code of Practice, PMCPA, Sanofi-Aventis
Boehringer Ingelheim has fallen foul of the ABPI Code of Practice on five counts in a row over an advertisement …
Amgen plant will boost Boehringer Ingelheim’s US presence
January 21, 2011Manufacturing and Production Abgenix, Amgen, Boehringer Ingelheim, Vectibix, panitumumab, pharma manufacturing
Germany’s Boehringer Ingelheim has agreed to buy a development and manufacturing facility in Fremont, California, from leading biotechnology firm Amgen. …
ABPI warns of postcode prescribing
January 21, 2011Sales and Marketing ABPI, Cancer Drugs Fund, NICE, cancer drug prescribing, postcode prescribing
The ABPI has said the government’s forthcoming Cancer Drugs Fund could increase the problems of postcode prescribing. The UK industry …
Double Helix expands market research division
January 21, 2011Medical Communications Arijit Ray, Aude Mircovich, Double Helix, Munna Vio, appointment, medical communications
Double Helix has appointed Munna Vio, Arijit Ray and Aude Mircovich (pictured) to its London-based global market research team. Munna …
Pharma manufacturing news in brief
January 21, 2011Manufacturing and Production Cambrex, Faron Pharmaceuticals, McNeil Consumer Healthcare, NextPharma Technologies, Rentschler Biotechnologie, Sandoz, ShangPharma, Sun European Partners, Teva Pharmaceuticals USA, Unilife Corp
Another J&J recall in the US, plus a round-up of product recalls, acquisitions, facility updates and new contracts in the …
Anne-Marie Rodriguez de Killeen to lead CCA
January 20, 2011Medical Communications Anne-Marie Rodriguez de Killeen, CCA, CCC, Chandler Chicco, appointment, medical communications
Chandler Chicco Companies Europe has promoted Anne-Marie Rodriguez de Killeento managing director for Chandler Chicco Agency. In addition to leading …
Penn Pharma appoints Wyeth’s Edward Rowland
January 20, 2011Manufacturing and Production, Research and Development Edward Rowland, Penn Pharma, appointment, manufacturing and production, research and development
Edward Rowland has joined Wales-based pharmaceutical drug developer and manufacturer Penn Pharma as head of operational analytical services. He moves …
Health Bill continues fast pace of NHS reform
January 20, 2011Sales and Marketing GP consortia, NHS, NHS Commissioning Board, NHS reforms, NICE, QALY
The government has outlined its draft Health and Social Care Bill, making some minor concessions to critics but promising no …
Astellas breaks ground on $95m antibody facility
January 20, 2011Manufacturing and Production Agensys, Astellas, antibodies, antibody
Astellas has broken ground on a $95 million R&D and manufacturing facility in Santa Monica, USA, that will also serve …
Caution raised on statins in healthy people
January 20, 2011Sales and Marketing Cochrane, Crestor, Lipitor, statin, statin prescribing
Researchers have warned of a lack of evidence to support prescribing statins in patients at low risk of developing heart …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
